Medical management of primary sclerosing cholangitis.
作者信息
Rabiee Atoosa, Levy Cynthia
机构信息
Department of Hepatology University of Miami School of Medicine Miami FL.
出版信息
Clin Liver Dis (Hoboken). 2014 Apr 1;3(3):48-51. doi: 10.1002/cld.319. eCollection 2014 Mar.
Abstract
摘要
相似文献
1
Medical management of primary sclerosing cholangitis.原发性硬化性胆管炎的医学管理
Clin Liver Dis (Hoboken). 2014 Apr 1;3(3):48-51. doi: 10.1002/cld.319. eCollection 2014 Mar.
2
Cholangiocarcinoma complicating primary sclerosing cholangitis.胆管癌合并原发性硬化性胆管炎。
Ann Surg. 1991 Jan;213(1):21-5. doi: 10.1097/00000658-199101000-00004.
3
Surgical management of ulcerative colitis in the presence of primary sclerosing cholangitis.原发性硬化性胆管炎患者溃疡性结肠炎的外科治疗
Dis Colon Rectum. 2003 Feb;46(2):173-8. doi: 10.1007/s10350-004-6520-6.
4
Diagnosis and management of cholangiocarcinoma in primary sclerosing cholangitis.原发性硬化性胆管炎中胆管癌的诊断与管理
J Gastrointest Surg. 1999 Jul-Aug;3(4):357-67; discussion 367-8. doi: 10.1016/s1091-255x(99)80051-1.
5
Sclerosing cholangitis.硬化性胆管炎
Curr Opin Gastroenterol. 2005 May;21(3):348-53. doi: 10.1097/01.mog.0000155359.43763.cc.
6
Sclerosing cholangitis.硬化性胆管炎
Curr Opin Gastroenterol. 2006 May;22(3):288-93. doi: 10.1097/01.mog.0000218966.78558.67.
7
Primary sclerosing cholangitis is associated with nonsmoking: a case-control study.原发性硬化性胆管炎与不吸烟有关：一项病例对照研究。
Gastroenterology. 1996 May;110(5):1496-502. doi: 10.1053/gast.1996.v110.pm8613055.
8
Primary sclerosing cholangitis.原发性硬化性胆管炎
Gastroenterol Nurs. 2007 Mar-Apr;30(2):102-5; quiz 105-7. doi: 10.1097/01.SGA.0000267929.62298.64.
9
Increased risk of colorectal cancer and dysplasia in patients with Crohn's colitis and primary sclerosing cholangitis.克罗恩病结肠炎和原发性硬化性胆管炎患者结直肠癌和异型增生的风险增加。
Dis Colon Rectum. 2011 Nov;54(11):1392-7. doi: 10.1097/DCR.0b013e31822bbcc1.
10
Primary sclerosing cholangitis.原发性硬化性胆管炎
Postgrad Med J. 1983;59 Suppl 4:99-105.
引用本文的文献
1
Novel histological scoring for predicting disease outcome in primary sclerosing cholangitis.原发性硬化性胆管炎疾病结局预测的新型组织学评分。
Histopathology. 2022 Aug;81(2):192-204. doi: 10.1111/his.14677. Epub 2022 May 31.
2
Primary Sclerosing Cholangitis: Therapeutic Options and Surveillance Management.原发性硬化性胆管炎：治疗选择与监测管理
Clin Med Insights Gastroenterol. 2016 Jun 9;9:25-9. doi: 10.4137/CGast.S38451. eCollection 2016.
本文引用的文献
1
Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management.原发性硬化性胆管炎的发病机制及诊治进展。
Gastroenterology. 2013 Sep;145(3):521-36. doi: 10.1053/j.gastro.2013.06.052. Epub 2013 Jul 1.
2
Primary sclerosing cholangitis.原发性硬化性胆管炎。
Lancet. 2013 Nov 9;382(9904):1587-99. doi: 10.1016/S0140-6736(13)60096-3. Epub 2013 Jun 28.
3
Randomised clinical trial: vancomycin or metronidazole in patients with primary sclerosing cholangitis - a pilot study.随机临床试验：原发性硬化性胆管炎患者中万古霉素或甲硝唑的应用——一项初步研究。
Aliment Pharmacol Ther. 2013 Mar;37(6):604-12. doi: 10.1111/apt.12232. Epub 2013 Feb 5.
4
Association between reduced levels of alkaline phosphatase and survival times of patients with primary sclerosing cholangitis.碱性磷酸酶水平降低与原发性硬化性胆管炎患者生存时间的关系。
Clin Gastroenterol Hepatol. 2013 Jul;11(7):841-6. doi: 10.1016/j.cgh.2012.12.032. Epub 2013 Jan 22.
5
Improvement of serum alkaline phosphatase to <1.5 upper limit of normal predicts better outcome and reduced risk of cholangiocarcinoma in primary sclerosing cholangitis.血清碱性磷酸酶改善至 <1.5 正常值上限可预测原发性硬化性胆管炎的更好结局和降低胆管癌风险。
J Hepatol. 2013 Feb;58(2):329-34. doi: 10.1016/j.jhep.2012.10.013. Epub 2012 Oct 22.
6
The safety and efficacy of oral docosahexaenoic acid supplementation for the treatment of primary sclerosing cholangitis - a pilot study.口服二十二碳六烯酸治疗原发性硬化性胆管炎的安全性和有效性 - 一项初步研究。
Aliment Pharmacol Ther. 2012 Jan;35(2):255-65. doi: 10.1111/j.1365-2036.2011.04926.x. Epub 2011 Nov 30.
7
Diagnosis and management of primary sclerosing cholangitis.原发性硬化性胆管炎的诊断与管理
Hepatology. 2010 Feb;51(2):660-78. doi: 10.1002/hep.23294.
8
High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis.高剂量熊去氧胆酸治疗原发性硬化性胆管炎。
Hepatology. 2009 Sep;50(3):808-14. doi: 10.1002/hep.23082.
9
EASL Clinical Practice Guidelines: management of cholestatic liver diseases.欧洲肝脏研究学会临床实践指南：胆汁淤积性肝病的管理
J Hepatol. 2009 Aug;51(2):237-67. doi: 10.1016/j.jhep.2009.04.009. Epub 2009 Jun 6.
10
High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study.高剂量熊去氧胆酸治疗原发性硬化性胆管炎：一项为期5年的多中心随机对照研究。
Gastroenterology. 2005 Nov;129(5):1464-72. doi: 10.1053/j.gastro.2005.08.017.
Zotero 插件